NBY News and Press, NovaBay Pharmaceuticals Inc. From 10/18/22

NovaBay Pharmaceuticals ( NYSE: NBY ) on Tuesday said it received significant orders for DERMAdoctor Kakadu C anti-aging serum ahead of the holiday season. "These orders will favorably impact DERMAdoctor’s revenue contribution for the 2022 third and fourth ...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces significant orders for DERMAdoctor ® Kakadu ® C 20% Vitamin C Serum with Ferulic Acid & Vitamin E. “We are excited to share that one of our best-selling products, DERMAdocto...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock We’re starting off the trading week with a look at the biggest pre-market stock movers for Monday morning! Moving stocks this morning are a delisting notice, a corporate update, and more....

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that select Avenova brand products and all DERMAdoctor brand products will...

NovaBay Pharmaceuticals ( NYSE: NBY ) said it had received a notice from the NYSE that its stock had been selling for a low price per share for a substantial period of time. Under the NYSE guide, the company could either do a reverse stock split of its stock...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that on October 3, 2022 it received a notice from the NYSE American LLC that the Company’s common stock has been selling for a low price per share for a substantial period of time. As a result, pursu...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that management will present at the Ladenburg Thalmann 2022 Healthcare Conf...

NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the September Life Sciences Virtual Investor Conference are now available for on-demand viewing. REGISTER NOW OR...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that management will present at the Virtual Life Sciences Investor Forum on Th...

NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Virtual Investor Conference to be held on September 15 th . Individual investors, institutional ...